Strategies to target drugs to gliomas and CNS metastases of solid tumors

B. Milojkovic Kerklaan, O. van Tellingen, A. D.R. Huitema, J. H. Beijnen, W. Boogerd, J. H.M. Schellens, D. Brandsma

Research output: Contribution to journalReview articlepeer-review

17 Citations (Scopus)

Abstract

The treatment for central nervous system metastases of solid tumors and gliomas is limited as the blood–brain barrier (BBB) is an obstacle to systemic therapy. Here, we review the physiochemical properties of the BBB and both current and new drug strategies to penetrate brain tumors. We focus on targeting receptor- or carrier-mediated transport mechanisms over the BBB used by drug conjugates, nanoparticles, polymer-based nanocarriers, siRNA, and antibodies.

Original languageEnglish
Pages (from-to)428-440
Number of pages13
JournalJournal of Neurology
Volume263
Issue number3
DOIs
Publication statusPublished - 1 Mar 2016
Externally publishedYes

Keywords

  • Antibodies
  • Brain metastases
  • Glioma
  • Nanoparticles
  • Polymer-based nanocarriers
  • siRNA

Fingerprint

Dive into the research topics of 'Strategies to target drugs to gliomas and CNS metastases of solid tumors'. Together they form a unique fingerprint.

Cite this